Meta-Analysis and Systematic Review of HLA DQ2/DQ8 in Adults with Celiac Disease
International Journal of Molecular Sciences · 07.01.2023 · 24 (2) · 1188
DOI: 10.3390/ijms24021188 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 07.01.2023. Verfasst von Sara Aboulaghras und 9 weiteren Autor:innen. Beteiligte Einrichtung: Physiology and Physiopathology Team, Faculty of Sciences, Genomic of Human Pathologies Research, Mohammed V University, Rabat 10100, Morocco. Hauptthemen laut MEDLINE: Celiac Disease. Die Arbeit wurde bisher 55-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Although people with human leukocyte antigens (HLA) DQ2 and/or DQ8 are more likely to develop celiac disease (CD), the condition cannot be fully explained by this genetic predisposition alone. Multiple, as yet unidentified, factors contribute to the genesis of CD, including genetics, the environment, and the immune system. In order to provide insight into a prospective possibility and an expanded screening technique, we aim to undertake a comprehensive and meta-analytical study of the assessment and distribution of HLA class II (HLA-DQ2/DQ8) in adult CD patients. A systematic review was conducted using an electronic search of databases (PubMed, Google Scholar, Embase, and Direct Science) from January 2004 to February 2022. DQ2/DQ2 homozygotes have the highest risk of developing CD. DQ2/DQ8 typing is an effective test to exclude CD from the differential diagnosis of a patient with CD symptoms. Although other non-HLA genes have been associated with CD, they are rarely considered at diagnosis because they account for only a small proportion of the heritability of CD. This finding, together with the information gathered previously, may be useful in considering widely available and economically feasible screening options for celiac disease in young people.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Physiology and Physiopathology Team, Faculty of Sciences, Genomic of Human Pathologies Research, Mohammed V University, Rabat 10100, Morocco.
- Laboratoire Immunologie, Institut National Hygiene, Rabat 10000, Morocco.
- National Research Council (CNR)-Institute of Translational Pharmacology (IFT), 67100 L'Aquila, Italy.
- Laboratory of Zoology and General Biology, Faculty of Sciences, Mohammed V University in Rabat, Rabat 10100, Morocco.
- Department of Clinical Laboratory Sciences, Faculty of Applied Medical Sciences, Najran University, Najran 61441, Saudi Arabia.
- Faculty of Data Science and Information Technology, INTI International University, Nilai 71800, Malaysia.
ORCID-Profile: Daniela Piancatelli, Abdelaali Balahbib, Mohammed Merae Alshahrani, Ahmed Abdullah Al Awadh, Khang Wen Goh, Long Chiau Ming, Abdelhakim Bouyahya
Zitieren
APA
Aboulaghras, S., Piancatelli, D., Taghzouti, K., Balahbib, A., Alshahrani, M. M., Al Awadh, A. A., Goh, K. W., Ming, L. C., Bouyahya, A., & Oumhani, K. (2023). Meta-Analysis and Systematic Review of HLA DQ2/DQ8 in Adults with Celiac Disease. International Journal of Molecular Sciences, 24(2), 1188. https://doi.org/10.3390/ijms24021188
Vancouver
Aboulaghras S, Piancatelli D, Taghzouti K, Balahbib A, Alshahrani MM, Al Awadh AA, et al. Meta-Analysis and Systematic Review of HLA DQ2/DQ8 in Adults with Celiac Disease. International Journal of Molecular Sciences. 2023;24(2):1188. doi:10.3390/ijms24021188
BibTeX
@article{Aboulaghras2023,
author = {Aboulaghras, Sara and Piancatelli, Daniela and Taghzouti, Khalid and Balahbib, Abdelaali and Alshahrani, Mohammed Merae and Al Awadh, Ahmed Abdullah and Goh, Khang Wen and Ming, Long Chiau and Bouyahya, Abdelhakim and Oumhani, Khadija},
title = {Meta-Analysis and Systematic Review of HLA DQ2/DQ8 in Adults with Celiac Disease},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {2},
pages = {1188},
doi = {10.3390/ijms24021188}
}
EUVIMED